1. |
Rassam F, Roos E, van Lienden KP, et al. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Arch Surg, 2018 Jan 19. doi: 10.1007/s00423-018-1649-2. [Epub ahead of print].
|
2. |
Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis, 1994, 14(2): 109-114.
|
3. |
王春, 陈哲宇, 曾勇, 等. Ⅳ型肝门部胆管癌的治疗体会. 中国普外基础与临床杂志, 2012, 19(1): 62-65.
|
4. |
Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg, 2014, 399(6): 707-716.
|
5. |
Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg, 2009, 250(2): 210-218.
|
6. |
Poruk KE, Pawlik TM, Weiss MJ. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg, 2015, 19(10): 1889-1899.
|
7. |
Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis, 2015, 30(2): 159-171.
|
8. |
Croome KP, Rosen CB, Heimbach JK, et al. Is liver transplantation appropriate for patients with potentially resectable de novo hilar cholangiocarcinoma? J Am Coll Surg, 2015, 221(1): 130-139.
|
9. |
van Gulik TM, Gouma DJ. Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol, 2007, 14(7): 1969-1971.
|
10. |
Zeng N, Tao H, Fang C, et al. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type Ⅲ hilar cholangiocarcinoma. World J Surg Oncol, 2016, 14(1): 44.
|
11. |
Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet, 2005, 366(9493): 1303-1314.
|
12. |
Olthof PB, Wiggers JK, Groot Koerkamp B, et al. Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization. J Am Coll Surg, 2017, 225(3): 387-394.
|
13. |
Ribero D, Zimmitti G, Aloia TA, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg, 2016, 223(1): 87-97.
|
14. |
Skrzypczyk C, Truant S, Duhamel A, et al. Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies. Ann Surg, 2014, 260(5): 865-870.
|
15. |
Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1 059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg, 2007, 204(5): 854-862.
|
16. |
Brandi G, Venturi M, Pantaleo MA, et al. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center. Dig Liver Dis, 2016, 48(3): 231-241.
|
17. |
Coelen RJ, Wiggers JK, Nio CY, et al. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford), 2015, 17(6): 520-528.
|
18. |
Wang M, Wang J, Sun H, et al. Time-dependent toxicity of cadmium telluride quantum dots on liver and kidneys in mice: histopathological changes with elevated free cadmium ions and hydroxyl radicals. Int J Nanomedicine, 2016, 11: 2319-2328.
|
19. |
Sato K, Hall C, Glaser S, et al. Pathogenesis of Kupffer Cells in Cholestatic Liver Injury. Am J Pathol, 2016, 186(9): 2238-2247.
|
20. |
Ogawa A, Tagawa T, Nishimura H, et al. Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice. Gut, 2006, 55(1): 105-113.
|
21. |
Long Y, Dong X, Yuan Y, et al. Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress. J Clin Biochem Nutr, 2015, 57(1): 50-59.
|
22. |
Bagante F, Spolverato G, Weiss M, et al. Surgical management of intrahepatic cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on peri-operative outcomes. World J Surg, 2018 Jan 3. doi: 10.1007/s00268-017-4453-1. [Epub ahead of print].
|
23. |
Brauer DG, Fields RC, Tan BR Jr, et al. Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma. HPB (Oxford), 2018 Jan 19. pii: S1365-182X(17)31164-4. doi: 10.1016/j.hpb.2017.11.010. [Epub ahead of print].
|
24. |
戴海粟, 别平, 王曙光, 等. 联合肝动脉切除重建在肝门部胆管癌根治术中的临床研究. 中华外科杂志, 2018, 56(1): 41-46.
|
25. |
Xiao J, Zhu J, Liu Z, et al. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution. J Cancer Res Ther, 2017, 13(5): 756-760.
|
26. |
赵帅, 王许安, 刘颖斌. 肝门胆管癌的外科争议及围肝门切除. 肝胆胰外科杂志, 2016, 28(4): 346-350.
|
27. |
Xiang C, Chen Y, Shao M, et al. Three-dimensional quantitative evaluation of the segmental functional reserve in the cirrhotic liver using multi-modality imaging. Medicine (Baltimore), 2016, 95(9): e2719.
|
28. |
Yokoyama Y, Ebata T, Igami T, et al. The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg, 2016, 40(6): 1440-1447.
|
29. |
Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med, 1991, 325(8): 525-532.
|